Cargando…
P268 Impact of the 2020 COVID-19 lockdown in Switzerland on physical activity in patients with early breast cancer under aromatase-inhibitor therapy. A subanalysis of the SAKK 95/17 WISE trial
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013692/ http://dx.doi.org/10.1016/S0960-9776(23)00386-7 |
| _version_ | 1784906829513359360 |
|---|---|
| author | Hoefnagels, N. Gautier, A. Müller, A. Schär, S. Rosset, L. Mahbiz, N. Corke Schwitter, M. Güth, U. Jakob, A. Balmelli-Cattelan, C. Leo, C. Fehr, M. Thorn, D.R. Riniker, S. Chouiter-Djebaili, A. Musilova, J. Honecker, F. |
| author_facet | Hoefnagels, N. Gautier, A. Müller, A. Schär, S. Rosset, L. Mahbiz, N. Corke Schwitter, M. Güth, U. Jakob, A. Balmelli-Cattelan, C. Leo, C. Fehr, M. Thorn, D.R. Riniker, S. Chouiter-Djebaili, A. Musilova, J. Honecker, F. |
| author_sort | Hoefnagels, N. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10013692 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100136922023-03-15 P268 Impact of the 2020 COVID-19 lockdown in Switzerland on physical activity in patients with early breast cancer under aromatase-inhibitor therapy. A subanalysis of the SAKK 95/17 WISE trial Hoefnagels, N. Gautier, A. Müller, A. Schär, S. Rosset, L. Mahbiz, N. Corke Schwitter, M. Güth, U. Jakob, A. Balmelli-Cattelan, C. Leo, C. Fehr, M. Thorn, D.R. Riniker, S. Chouiter-Djebaili, A. Musilova, J. Honecker, F. Breast Poster Abstracts Elsevier Ltd. 2023-04 2023-03-14 /pmc/articles/PMC10013692/ http://dx.doi.org/10.1016/S0960-9776(23)00386-7 Text en Copyright © 2023 Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Poster Abstracts Hoefnagels, N. Gautier, A. Müller, A. Schär, S. Rosset, L. Mahbiz, N. Corke Schwitter, M. Güth, U. Jakob, A. Balmelli-Cattelan, C. Leo, C. Fehr, M. Thorn, D.R. Riniker, S. Chouiter-Djebaili, A. Musilova, J. Honecker, F. P268 Impact of the 2020 COVID-19 lockdown in Switzerland on physical activity in patients with early breast cancer under aromatase-inhibitor therapy. A subanalysis of the SAKK 95/17 WISE trial |
| title | P268 Impact of the 2020 COVID-19 lockdown in Switzerland on physical activity in patients with early breast cancer under aromatase-inhibitor therapy. A subanalysis of the SAKK 95/17 WISE trial |
| title_full | P268 Impact of the 2020 COVID-19 lockdown in Switzerland on physical activity in patients with early breast cancer under aromatase-inhibitor therapy. A subanalysis of the SAKK 95/17 WISE trial |
| title_fullStr | P268 Impact of the 2020 COVID-19 lockdown in Switzerland on physical activity in patients with early breast cancer under aromatase-inhibitor therapy. A subanalysis of the SAKK 95/17 WISE trial |
| title_full_unstemmed | P268 Impact of the 2020 COVID-19 lockdown in Switzerland on physical activity in patients with early breast cancer under aromatase-inhibitor therapy. A subanalysis of the SAKK 95/17 WISE trial |
| title_short | P268 Impact of the 2020 COVID-19 lockdown in Switzerland on physical activity in patients with early breast cancer under aromatase-inhibitor therapy. A subanalysis of the SAKK 95/17 WISE trial |
| title_sort | p268 impact of the 2020 covid-19 lockdown in switzerland on physical activity in patients with early breast cancer under aromatase-inhibitor therapy. a subanalysis of the sakk 95/17 wise trial |
| topic | Poster Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013692/ http://dx.doi.org/10.1016/S0960-9776(23)00386-7 |
| work_keys_str_mv | AT hoefnagelsn p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial AT gautiera p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial AT mullera p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial AT schars p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial AT rossetl p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial AT mahbizncorke p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial AT schwitterm p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial AT guthu p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial AT jakoba p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial AT balmellicattelanc p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial AT leoc p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial AT fehrm p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial AT thorndr p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial AT rinikers p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial AT chouiterdjebailia p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial AT musilovaj p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial AT honeckerf p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial |